Clinical trials sponsored by Seoul National University Hospital
24
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 2 1Phase 3 1Not applicable 22
Conditions studied
Recruiting trials led by Seoul National University Hospital
- A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System
- Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)
- Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function
- Controls for Respiratory Diseases
- Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
- KNOW-CKD Cohort, Phase II Study
- KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
- Korean College of Rheumatology Biologics and Targeted Therapy Registry
- PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism
- Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation
- Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
- Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation
- Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)
- Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
- Reduced Vaccine Response to HZ/su in SLE
- SCAR Burden of Left Atrium Guided cathEter Ablation sTrategy for Persistent Atrial Fibrillation
- SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
- Scout Dose of Resin Microspheres
- Seoul National University Airway Registry
- Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance
- Stress Management with Real-time Bio-signal Biofeedback
- Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency
- Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
- mHealth for Hypertensive Disorder of Pregnancy
Common questions
How many trials is Seoul National University Hospital recruiting for?
Seoul National University Hospital is the lead sponsor of 24 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.